Search research articles
Contact Us
Filters
Showing results (351-360 of 524) with videos related to
Page
of 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Rupa Juthani, Brian Madajewski, Barney Yoo, et al.
Histopathology
|
January 5, 2026
Analysis of SCLC subtype markers (ASCL1, NEUROD1, POU2F3, YAP1), DLL3, OTP, and TTF1 in 300 lung carcinoids and enteropancreatic neuroendocrine tumours
Jonathan Willner, Irfan Khan, Zeynep Tarcan, et al.
Investigational New Drugs
|
April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors
Geoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
JTO Clinical and Research Reports
|
January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring <i>KRAS</i> Mutations
Kathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
Nature Medicine
|
February 12, 2020
Regenerative lineages and immune-mediated pruning in lung cancer metastasis
Ashley M Laughney, Jing Hu, Nathaniel R Campbell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation
Soo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
Cancer Cell
|
February 16, 2017
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Eric E Gardner, Benjamin H Lok, Valentina E Schneeberger, et al.
EJNMMI Research
|
January 20, 2017
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P Crandall, Abdel K Tahari, Rosalyn A Juergens, et al.
Molecular Cancer
|
May 29, 2024
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, et al.
JCO Precision Oncology
|
May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer
N Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Page
of 53
Search research articles
Search
Showing results (351-360 of 524) with videos related to
Sort By:
Page
of 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Rupa Juthani, Brian Madajewski, Barney Yoo, et al.
Histopathology
|
January 5, 2026
Analysis of SCLC subtype markers (ASCL1, NEUROD1, POU2F3, YAP1), DLL3, OTP, and TTF1 in 300 lung carcinoids and enteropancreatic neuroendocrine tumours
Jonathan Willner, Irfan Khan, Zeynep Tarcan, et al.
Investigational New Drugs
|
April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors
Geoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
JTO Clinical and Research Reports
|
January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring <i>KRAS</i> Mutations
Kathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
Nature Medicine
|
February 12, 2020
Regenerative lineages and immune-mediated pruning in lung cancer metastasis
Ashley M Laughney, Jing Hu, Nathaniel R Campbell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation
Soo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
Cancer Cell
|
February 16, 2017
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Eric E Gardner, Benjamin H Lok, Valentina E Schneeberger, et al.
EJNMMI Research
|
January 20, 2017
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P Crandall, Abdel K Tahari, Rosalyn A Juergens, et al.
Molecular Cancer
|
May 29, 2024
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, et al.
JCO Precision Oncology
|
May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer
N Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Page
of 53